AQP4 and myasthenia gravis: Moreover, the NMOSD AQP4-Ab-negative phenotype may refer to other antigens targeted by a distinct mechanism37, as observed in the autoimmune disorder myasthenia gravis (MG) for which the acetylcholine receptor (AchR) antibody was found to be the disease’s biomarker.